[{"Assets_0_FY_USD":422202000.0,"CIK":"1595893","CommonStockSharesConverted_0_FY_shares":35915119.0,"CommonStockSharesOutstanding_0_FY_shares":35915119.0,"Country":"United States","EarningsPerShareBasic_1_FY_USD":-0.58,"EarningsPerShareBasic_4_FY_USD":-2.99,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"1579986704.0","NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":-57757000.0,"NetIncomeLossConverted_1_FY_USD":-20959000.0,"NetIncomeLossConverted_4_FY_USD":-72131000.0,"OfficialName":"Turning Point Therapeutics Inc. Common Stock","SP500":"nan","Sector":"Health Care","StockholdersEquity_0_FY_USD":404351000.0,"Ticker":"TPTX","filed":"20200318","footnote":"nan","form":"10-K","fp":"FY","fy":"2019.0","name":"TURNING POINT THERAPEUTICS, INC.","period":"20191231","qtrs":"0","uom":"USD"}]